Cboe UK GBp

Hikma Pharmaceuticals PLC (HIKL.XC)

Compare

2,284.00

-8.00

(-0.35%)

As of 9:53:42 AM GMT. Market Open.

No Tool

Measure

UNDO

Redo

All

Favorites

Text

Statistics

Technicals

Fibonacci

Markings

Lines

Annotation

Arrow

Line

Horizontal

Vertical

Rectangle

Trend Line

Measurement Line

Average Line

Callout

Channel

Check

Continuous

Crossline

Elliott Wave

Ellipse

Doodle

Fib Projection

Fib Arc

Fib Fan

Fib Time Zone

Focus

Gann Fan

Gartley

Heart

Pitchfork

Quadrant Lines

Ray

Regression Line

Fib Retracement

Star

Speed Resistance Arc

Speed Resistance Line

Time Cycle

Tirone Levels

Volume Profile

Cross

Loading Chart for HIKL.XC

Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg

Is Hikma Pharmaceuticals PLC (HIK.L) Among the U.K. Dividend Aristocrats for 2024?

Hikma Pharmaceuticals PLC's (LON:HIK) Stock Is Going Strong: Have Financials A Role To Play?

Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 95% Above Its Share Price

Stocks to watch this week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S

With 55% ownership, Hikma Pharmaceuticals PLC (LON:HIK) boasts of strong institutional backing

Hikma Pharmaceuticals (LON:HIK) shareholders have endured a 17% loss from investing in the stock three years ago

Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention Day

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Hikma Pharmaceuticals PLC (HIKL.XC)

Comparisons

Indicators

Technicals

Corporate Events

5.16%

13.86%

21.30%

21.04%

15.12%

20.99%

25.36%

548.86%

Recent News: HIKL.XC